nice work @MoneyLover91, Will be looking out for an acceleration of press coverage over the next few weeks. From Business News Australia this afternoon:
https://www.businessnewsaus.com.au/articles/joint-telehealth-development-to-assist-in-diagnosing-respiratory-disease.html
Two digital health companies have joined forces to expand access to telehealth services targeted specifically at diagnosing respiratory diseases. ResApp Health (ASX: RAP) will integrate its acute respiratory diagnostic test ResAppDx-EU into Phenix Health's telehealth smartphone app.
The partnership is a significant step toward accelerating diagnosis and treatment of respiratory diseasesconsidering users of Phenix Health's app no longer have to rely on additional hardware; diagnosis can occur entirely within a single telehealth session. By using machine learning algorithms ResAppDx-EU analyses patients' cough sounds to diagnose lower respiratory tract diseases such as pneumonia and asthma exacerbations.
Ultimately, the partnership will enable doctors to determine whether a patient should attend a hospital or clinic for additional care, thus conserving already strained healthcare resources.
With people around the world encouraged to remain at home as much as possible telehealth technology is becoming a vital tool to help slow the spread of the novel coronavirus, enabling sick patients to see a doctor at a distance, away from those most vulnerable in the broader community.
- Forums
- ASX - By Stock
- RAP
- Ann: ResAppDx-EU to be Deployed on Phenix Health Telehealth App
Ann: ResAppDx-EU to be Deployed on Phenix Health Telehealth App, page-88
-
-
- There are more pages in this discussion • 207 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online